Medicine
Xocova 125 mg tablet
Xocova 125 mg tablet is a prescription medicine containing Ensitrelvir for oral use, marketed by Shionogi, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store XOCOVA in the original package at 20°C to 25°C (68°F to 77°F)…
Key facts
- Active ingredient (INN)
- Ensitrelvir
- Brand
- Xocova
- Strength
- 125 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 1 blister pack
- Marketing authorisation holder
- Shionogi
- Manufacturer
- Shionogi
- Origin register
- US FDA, United States
- Storage
- Store XOCOVA in the original package at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J05AE16 Ensitrelvir
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 2 July 2026
- Identifiers
- RxCUI 2745993, 2745999, 2746000 +1DailyMed set ID 526acf60-abc3-2cc2-e063-6294a90affa6NDC 59630-711Application NDA220442
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 blister pack in 1 carton / 7 tablet in 1 blister pack | 59630-711-07 | Shionogi | 2 July 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Ensitrelvir is a prescription medicine indicated for post-exposure prophylaxis of coronavirus disease 2019 (COVID-19) in adults and adolescents 12 years of age and older following contact with an individual who has COVID-19. MedsAcross supplies Ensitrelvir for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about EnsitrelvirFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- XOCOVA prescribing information (Shionogi) · U.S. National Library of Medicine, DailyMed
- Zokovea: European public assessment report (EPAR) · European Medicines Agency
Need Xocova 125 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.